Literature DB >> 33116522

In vitro Effect of Silver Nanoparticles on Blastocystis hominis.

Mohamed Saad Younis1, Eman Abd El Rahman Abououf1, Ali El Saeed Ali1, Sara Mohamed Abd Elhady2, Rita Maher Wassef2.   

Abstract

INTRODUCTION: This study aims to assess the efficacy of silver nanoparticles (Ag Nps) alone and combined with metronidazole (Ag Nps + MTZ) as potential alternative therapeutic agents for Blastocystis hominis.
METHODS: The parasites were challenged with Ag Nps, Ag Nps + MTZ and MTZ. To assess the efficacy of drugs, counting of viable parasites was done after 1, 2, and 3 hours of adding the drugs.
RESULTS: Blastocystis hominis count was reduced by 20.72%, 28.23%, and 18.92% after one hour of adding Ag Nps, Ag Nps + MTZ, and MTZ, respectively. Cysts count was further reduced by 51.49%, 61.61%, and 40.78% after 2 hours and by 71.69%, 79.67%, and 62.65% after 3 hours of adding the drugs in the same order, respectively.
CONCLUSION: There was a statistically significant difference (P<0.05) in the in vitro growth inhibition of the parasite over the different time intervals when using the tested drugs against the control drug.
© 2020 Younis et al.

Entities:  

Keywords:  Blastocystis hominis; eosin brilliant cresyl blue stain; metronidazole; silver nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 33116522      PMCID: PMC7588274          DOI: 10.2147/IJN.S272532

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  18 in total

1.  Blastocystis: to treat or not to treat...

Authors:  Christina M Coyle; Julie Varughese; Louis M Weiss; Herbert B Tanowitz
Journal:  Clin Infect Dis       Date:  2011-11-10       Impact factor: 9.079

2.  Quantitative dielectrophoretic tracking for characterization and separation of persistent subpopulations of Cryptosporidium parvum.

Authors:  Yi-Hsuan Su; Mikiyas Tsegaye; Walter Varhue; Kuo-Tang Liao; Lydia S Abebe; James A Smith; Richard L Guerrant; Nathan S Swami
Journal:  Analyst       Date:  2013-11-14       Impact factor: 4.616

3.  Chitosan and silver nanoparticles: promising anti-toxoplasma agents.

Authors:  M R Gaafar; R F Mady; R G Diab; Th I Shalaby
Journal:  Exp Parasitol       Date:  2014-05-19       Impact factor: 2.011

4.  Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

Authors:  Arutchelvan Rajamanikam; Suresh Kumar; Chandramathi Samudi; Madhav Kudva
Journal:  Parasitol Res       Date:  2018-06-05       Impact factor: 2.289

Review 5.  Blastocystis hominis revisited.

Authors:  D J Stenzel; P F Boreham
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Blastocystis sp. subtype 5: a possibly zoonotic genotype.

Authors:  Yiming Yan; Shuilian Su; Jinhua Ye; Xiaofang Lai; Riyong Lai; Hua Liao; Guifeng Chen; Ruiqi Zhang; Zhiping Hou; Xiaobing Luo
Journal:  Parasitol Res       Date:  2007-07-30       Impact factor: 2.289

7.  ANTIPARASITIC ACTIVITY OF SILVER AND COPPER OXIDE NANOPARTICLES AGAINST ENTAMOEBA HISTOLYTICA AND CRYPTOSPORIDIUM PARVUM CYSTS.

Authors:  Halim A Saad; Mohamed I Soliman; Ahmed M Azzam; B Mostafa
Journal:  J Egypt Soc Parasitol       Date:  2015-12

8.  Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria.

Authors:  Okkyoung Choi; Zhiqiang Hu
Journal:  Environ Sci Technol       Date:  2008-06-15       Impact factor: 9.028

Review 9.  Health Impact of Silver Nanoparticles: A Review of the Biodistribution and Toxicity Following Various Routes of Exposure.

Authors:  Zannatul Ferdous; Abderrahim Nemmar
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

Review 10.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.